The currently demonstrated ability of Indicaxanthin to inhibit the active form of hIKKβ may, then, suggest the phytochemical as a new lead compound to synthesize novel and more potent IKKβ inhibitors for the treatment of cancer and inflammation-related conditions. The gene discussed is IKBKB; the disease is cancer.